Epigenetic Remodeling via ARID2 Knockdown Reveals Synergistic Sensitivity to BET and EGFR/HER2 Inhibition in 3D Melanoma Model
This study demonstrates that ARID2 deficiency in melanoma creates a context-specific vulnerability to the synergistic effects of combined EGFR/HER2 and BET inhibition, a therapeutic strategy that is more effectively revealed through 3D spheroid models than traditional 2D cultures.